Doosan Heavy Industries & Construction Co. (DHIC) will expedite its self-rescue plan by raising 2.2 trillion won in the sale of Doosan Engineering & Construction Co., its stake in Doosan Infracore Co., and new shares worth 1.3 trillion won.
DHIC owns Doosan Engineering and has a 36 percent stake in Doosan Infracore, the group's construction equipment maker.
Last March, DHIC received a cash injection of 3 trillion won from its creditors, which should be paid within this year.
Doosan Group vowed to repay 1 trillion won in debts by the end of the year by selling its assets.
The power plant builder has since sold its 27-hole golf course Club Mow for 185 billion won and venture capital firm Neoplux Co. for 73 billion won.
Doosan Group's holding company, Doosan Corp., sold its 18.05 percent stake in battery foil maker Doosan Solus Co. for 238 billion won, with 34.88 percent held by key stockholders, including Doosan Group Chairman Park, sold for 460 billion won.
Doosan also sold its business division and oil pressure machine maker Doosan Mottrol for 453 billion won, Doosan Group said.
The group is also set to sell its headquarters building Doosan Tower in downtown Seoul for 800 billion won next Monday.


Supreme Court Asked to Reinstate Mail-Order Access to Abortion Pill Mifepristone
Google Secures Pentagon AI Deal for Classified Projects
Why Paycom Was Named a 2026 Platinum Employer on the Where You Work Matters List
Amazon Stock Dips Despite Record Earnings as AI Infrastructure Spending Surges
GameStop Eyes eBay Acquisition as Stock Prices Surge After Hours
T-Mobile Beats Q1 Earnings Expectations on Strong Postpaid Growth
TSMC Exits Arm Holdings with $231 Million Share Sale Amid Strategic Portfolio Shift
China’s Ultra-Cheap EV Boom: Why Electric Cars Cost Far Less Than in the U.S.
Starbucks Raises 2026 Outlook as Turnaround Strategy Boosts Sales and Earnings
Air Liquide Q1 Revenue Misses Estimates Amid Currency and Energy Headwinds
Coles Group Q3 Sales Rise Driven by Supermarkets and E-Commerce Growth
AstraZeneca Q1 2026 Earnings Surge on Strong Oncology and Rare Disease Drug Sales
Micro Systemation Reports Q1 Loss Amid Strategic Investments and Revenue Growth
Australia Targets Meta, Google, and TikTok With New News Payment Tax Proposal
Novartis Q1 2026 Earnings Miss Expectations as Generic Competition Pressures Sales
WuXi AppTec Stock Surges on Strong Q1 Earnings and CRDMO Demand Growth 



